Choosing a NetSuite ERP system in life sciences is not just an accounting software decision. It is a decision about how your company will control spend, document approvals, manage regulated inventory, support audits, and scale from clinical activity to commercial operations without rebuilding the back office every year.
For biotech, biopharma, medical device, CDMO, specialty pharmacy, and adjacent healthcare operators, the question is rarely, “Can NetSuite handle finance?” The more important question is, “Can our NetSuite environment reflect how a regulated life sciences business actually operates?”
The answer depends on design. NetSuite provides a strong ERP foundation, but life sciences value comes from the way finance, procurement, quality, inventory, compliance, and reporting are configured around your operating model.
Why life sciences companies choose NetSuite
Life sciences companies often outgrow entry-level accounting tools before they realize it. QuickBooks, Sage, spreadsheets, disconnected AP platforms, and manually maintained approval matrices may work in the earliest stages, but they become risky as the organization adds entities, vendors, CROs, CMOs, 3PLs, quality requirements, board reporting, or public company controls.
A NetSuite ERP system gives growing organizations a single operational and financial backbone. Instead of reconciling data across disconnected systems, teams can manage core business processes in one environment with consistent records, roles, workflows, and reporting.
That matters because life sciences companies usually scale in uneven stages. A clinical-stage biotech may suddenly need IPO-ready controls. A CDMO may need project accounting by sponsor and phase. A specialty pharmacy may need tighter inventory visibility and payer-specific reporting. A medical device company may need multi-country consolidation and revenue models that reflect leases, service agreements, or usage-based billing.
NetSuite is often a fit because it can support multi-entity operations, role-based workflows, approval controls, inventory, purchasing, financial reporting, and integrations. But it should be implemented with a clear understanding of regulated operations, not as a generic finance tool.
What a NetSuite ERP system should support in life sciences
A well-designed NetSuite environment should connect the operational activities that drive finance. In life sciences, that means the ERP should not only record transactions after the fact. It should help enforce the process before the transaction becomes a control issue, audit issue, or reporting problem.
| Operating area | What a well-designed NetSuite ERP system should support | Why it matters in life sciences |
|---|---|---|
| Finance and close | Multi-entity accounting, consolidated reporting, intercompany activity, accruals, fixed assets, and audit-ready close processes | Enables accurate reporting for boards, investors, auditors, and public company readiness |
| Procure-to-pay | Vendor onboarding, purchase requests, purchase orders, invoice capture, approvals, payment controls, and contract alignment | Reduces uncontrolled spend and creates evidence for financial and compliance reviews |
| Inventory and supply chain | Item masters, lot tracking, location visibility, 3PL integrations, expiry controls, and inventory costing | Supports traceability, product availability, recall readiness, and financial accuracy |
| Quality and compliance | Controlled workflows, quality events, documentation, approval history, and exception handling | Helps teams operate with consistent evidence instead of scattered files and emails |
| Revenue and commercial operations | Contract-driven billing, revenue recognition, gross-to-net inputs, returns, rebates, and customer reporting | Supports commercial launch and reduces manual revenue adjustments |
| Reporting | Real-time dashboards, operational KPIs, financial statements, and role-based reporting | Gives leadership a current view of performance without waiting for spreadsheet rebuilds |
The key is integration. If procurement sits in one system, contracts in another, inventory in another, and approvals in email, NetSuite becomes only a partial source of truth. For regulated businesses, partial visibility is often where risk accumulates.
Expect stronger financial controls, not just better accounting
For many life sciences organizations, the first visible improvement from NetSuite is financial discipline. A properly configured environment can standardize the chart of accounts, enforce approval routing, support multi-entity consolidation, and reduce spreadsheet-based close activity.
This is especially important for companies preparing for an audit, financing event, acquisition, IPO readiness, or SOX-aligned control environment. NetSuite can support segregation of duties, role-based access, transaction approvals, system-generated audit trails, and management reporting. Those capabilities help finance teams move away from “trust me” processes and toward evidence-based controls.
In practice, this means purchase requests route based on policy, invoices match to approved purchase orders, payments follow controlled workflows, and executives can see cash, liabilities, commitments, and entity-level performance without waiting for manual consolidation.
If your close process depends on downloading data, rebuilding reports, chasing approvals, and manually reconciling vendor or entity activity, the ERP implementation should address those root causes. Otherwise, NetSuite becomes a better ledger attached to the same old process.
For a real-world example of ERP selection and implementation during launch preparation, see Archer’s case study on selecting and implementing NetSuite while preparing for commercial launch.
Expect compliance-ready workflows, but not automatic compliance
A common misconception is that implementing NetSuite automatically makes a life sciences company compliant. It does not. NetSuite can provide the system foundation for compliant processes, but compliance depends on configuration, validation strategy, user access, workflow design, documentation, training, and ongoing governance.
For example, electronic records and electronic signatures are governed by 21 CFR Part 11 when they are used in FDA-regulated contexts. The system needs appropriate controls for record integrity, user accountability, audit trails, access, and signature meaning. Whether a given NetSuite process falls into scope depends on how the company uses it and what regulated records are maintained there.
A life sciences NetSuite implementation should therefore define which processes are GxP-relevant, which records require additional controls, and how the company will maintain evidence over time. That may include documented requirements, testing, change control, approval history, access reviews, and controlled deployment practices.
Archer has written separately about what 21 CFR Part 11 actually requires from your ERP system, which is worth reading if your NetSuite environment will touch regulated records or quality workflows.
Expect procurement to become a control point
In life sciences, procurement is rarely just purchasing. It is where vendor qualification, budget control, contract compliance, delegated authority, quality obligations, and cash management intersect.
A strong NetSuite ERP system should help answer practical questions such as:
- Is this vendor approved for the type of work being requested?
- Does the purchase request comply with the contract and budget?
- Was the approval routed to the correct person based on amount, department, category, or entity?
- Can the invoice be matched to the purchase order and receipt?
- Can auditors see who approved what, when, and why?
This is where life sciences companies often gain significant operational leverage. Instead of discovering issues at month-end, NetSuite can enforce controls at the point of request, purchase order creation, invoice processing, and payment.
For companies managing CROs, CMOs, consultants, lab suppliers, specialty distributors, or healthcare vendors, procurement design should be handled early. Vendor onboarding, contract lifecycle management, OCR invoice capture, and approval automation are not side features. They are core controls for regulated growth.
Expect inventory and supply chain design to be industry-specific
Inventory requirements vary widely across life sciences. A cell therapy company may need patient-specific tracking. A CDMO may need sponsor-specific material segregation. A medical device company may need serial or lot traceability and service-related inventory. A specialty pharmacy may need DSCSA-related data flows, payer-aware inventory reporting, or 3PL visibility.
NetSuite can support inventory management, lot tracking, item records, locations, costing, and integrations, but those capabilities need to be aligned with the business model. The item master, lot structure, location hierarchy, transaction flow, and integration logic must reflect how products actually move through the organization.
This is where generic ERP design often falls short. It may capture inventory quantity, but not the operational context needed for traceability, quality review, recall readiness, expiry management, chain-of-custody, or financial reporting.
For complex manufacturing and outsourced operations, NetSuite should be designed around the realities of CROs, CMOs, CDMOs, 3PLs, distributors, labs, and specialty partners. Integration strategy is critical because much of the operational activity may happen outside your four walls.
What not to expect from NetSuite out of the box
NetSuite is a flexible ERP platform, but flexibility is not the same as industry readiness. Life sciences companies should not expect a generic NetSuite deployment to automatically solve regulated operational complexity.
You should not expect out-of-the-box configuration to fully address Part 11 considerations, SOX controls, GxP validation, complex gross-to-net accounting, DSCSA workflows, 340B segregation, sponsor-specific CDMO accounting, chain-of-custody, or quality event management without deliberate design.
You also should not expect technology to fix unclear policies. If your approval matrix is inconsistent, your vendor data is incomplete, your chart of accounts is not scalable, or your quality ownership is undefined, the ERP will expose those issues. That is a good thing, but only if the implementation team is prepared to resolve them.
The best NetSuite implementations treat configuration as a business design exercise. The system should reflect how the company wants to operate at scale, not simply digitize today’s workarounds.
What implementation typically feels like
A life sciences NetSuite implementation should be structured, evidence-driven, and cross-functional. Finance cannot design the system alone. Quality, procurement, supply chain, IT, legal, commercial, and operations often need to participate because the ERP touches shared controls and shared data.
| Implementation phase | What happens | What to watch closely |
|---|---|---|
| Discovery and blueprint | The team maps current processes, future-state requirements, entities, systems, reports, controls, and integrations | Do not limit discovery to finance if regulated operations depend on ERP data |
| System design | NetSuite configuration is designed around roles, workflows, records, approval logic, reporting, and integrations | Avoid copying broken legacy workflows into a new system |
| Data migration | Vendors, customers, open transactions, item records, chart of accounts, balances, and historical data are cleansed and loaded | Poor master data can undermine reporting and controls from day one |
| Testing and validation | Users test real business scenarios, approvals, reports, integrations, security, and exception paths | Test exceptions, not just happy-path transactions |
| Cutover and stabilization | The organization transitions to NetSuite, resolves issues, and trains users on the new operating model | Hypercare should focus on adoption, control discipline, and reporting confidence |
The implementation should also define what happens after go-live. Regulated companies need ongoing governance for roles, workflow changes, master data, integrations, report updates, and control evidence. NetSuite is not a one-time project. It becomes part of the operating infrastructure of the business.
Signs your NetSuite ERP system is working
A successful NetSuite ERP system should be noticeable in daily operations, not just in board presentations. The finance team should spend less time rebuilding reports and more time analyzing performance. Procurement should have clearer control over requests, commitments, and vendor activity. Executives should see timely dashboards. Auditors should be able to trace approvals and transactions without lengthy evidence hunts.
Useful signs of success include faster close cycles, fewer manual reconciliations, cleaner approval evidence, improved spend visibility, stronger vendor controls, more reliable inventory reporting, and better alignment between operational activity and financial outcomes.
For life sciences companies, another important sign is scalability. The ERP should support the next stage of the business, whether that is adding entities, preparing for commercial launch, expanding internationally, integrating acquisitions, scaling manufacturing, or strengthening public company controls.
If the system only solves today’s accounting pain but cannot support the next regulatory or operational milestone, the implementation is too narrow.
Common mistakes to avoid
Life sciences ERP projects usually struggle for predictable reasons. The software is rarely the only issue. The bigger problems come from incomplete design, unclear ownership, and underestimating regulated complexity.
Common mistakes include treating NetSuite as a finance-only project, delaying compliance and control design until after go-live, over-customizing instead of standardizing, migrating poor-quality data, excluding quality or operations from design decisions, and leaving critical integrations outside the implementation scope.
Another mistake is selecting an implementation partner based only on general ERP experience. A life sciences NetSuite partner should understand how regulated companies operate, how audits are supported, how outsourced models affect data flow, and how financial controls intersect with quality and supply chain processes.
Archer’s white paper on scaling systems in life science from lab bench to commercial launch explores this timing issue in more depth.
How Archer Insights approaches NetSuite for life sciences
Archer Insights builds NetSuite systems for regulated life sciences operations, with compliance-ready implementation and purpose-built operational extensions. The goal is to help organizations operate from a single system of record while reducing disconnected processes, manual approvals, and audit evidence gaps.
Archer’s work is centered on life sciences and healthcare operating models, including native NetSuite modules, compliance-ready workflows, audit trail and SOX support, quality management system capabilities, vendor onboarding, AI-powered invoice OCR, 3PL and EHR integrations, contract lifecycle management, approval automation, and real-time dashboards and reporting.
That specialization matters because life sciences ERP is not only about getting transactions into NetSuite. It is about designing the system so transactions are controlled, traceable, reportable, and aligned with the way regulated businesses scale.